Trajenta Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each film-coated tablet contains 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-(= linagliptin) 5 mg.
Excipients/Inactive Ingredients: mannitol, starch pregelatinised, maize starch, copovidone, magnesium stearate, Opadry Pink (02F34337).

linagliptin

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug